Chargement en cours...
Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1
Recent clinical trials utilizing antigen-pulsed dendritic cells (DCs) have demonstrated increased survival of vaccinated cancer patients. Besides, the cytoplasmic transduction peptide (CTP) not only has an excellent transcellular efficiency but also shows a strong tendency to remain in the cytoplasm...
Enregistré dans:
| Publié dans: | Hum Vaccin Immunother |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7734070/ https://ncbi.nlm.nih.gov/pubmed/32401608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1732165 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|